Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2020–2022 · research · R21
In situ cancer cell specific synthesis of gold nanoclusters for radiosensitization of pancreatic cancer
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma
Michael Richard Green · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION
Ju-Seog Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2021 · research · R01
Stinging the Glioma Immune Landscape
Amy Beth Heimberger · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · grant · Academic Research
Targeted Inhibition of Autophagy for Treatment of Dormant Ovarian Cancer
Steven Millward · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2020–2025 · fellowship · Fellowship Award
Graduate Research Fellowship Program (GRFP)
Gregory Lizee · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2020–2024 · research · R01
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
Lawrence Kwong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
Khandan Keyomarsi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R50
Identifying the vulnerabilities in Mdm2 overexpressing cancer cells
Vinod Pant · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2023 · career development · K22
How HSP90 shapes genotype-phenotype relationships to alter treatment outcome in cancer
Georgios Karras · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously
Lawrence Kwong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · grant · Prevention
Active Living After Cancer: Combining a Physical Activity Program with Survivor Navigation
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2020–2025 · research · R50
Single Cell Spatial Analysis in Tissue
Jared Kyle Burks · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2023 · research · R03
Role of BHC80 in spermatogenesis
Marie-Claude Catherine Hofmann · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R00
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer
Aria Vaishnavi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · grant · CPRIT Scholar
Recruitment of Rising Stars
Veronika Fedirko · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2020–2025 · research · R37
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
Moran Amit · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors
John V. Heymach · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Coordination of DNA repair and transcription by ubiquitin modification at DNA double strand breaks
Bin Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Validation of Fibroblast-Derived PI16 as a Novel Target for pain Treatment
Andrew John Shepherd · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Mitigating radiation-induced cardiovascular disease by inhibiting premature aging
Jun-Ichi Abe · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
Paul Michael Cinciripini · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Role of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancer
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2022 · research · R01
Molecular mechanism of Mincle mediated NET formation: Implications for pneumonic sepsis
Jyotika Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R50
Modeling tumor heterogeneity and treatment resistance in small cell lung cancer
Catherine Allison Stewart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · grant · Academic Research
Artificial Intelligence for the Peer Review of Radiation Therapy Treatments
Laurence E Court · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2020–2025 · cooperative agreement · U01
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
Suresh T. Chari · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2023 · research · R21
Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors
John V. Heymach · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Breaking down tumor immune privilege through targeted hypoxia reduction
Michael A. Curran · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
Paul Michael Cinciripini · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Harnessing Aurora kinase inhibition‐induced cell death to enhance immunotherapy in HPV‐driven cancers
Faye Johnson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R50
Modeling tumor heterogeneity and treatment resistance in small cell lung cancer
Catherine Allison Stewart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
Henry Charles Manning · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2024 · award
Novel mechanisms of brain metastasis in aggressive breast cancers
Bisrat Debeb · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2020–2023 · cooperative agreement · U01
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
Ananth V Annapragada · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
UCHL5 as a regulator and therapeutic target in metastatic melanoma
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2020 · grant · Academic Research
Single-Cell Evaluation to Identify Tumor-stroma Niches Driving the Transition from In Situ to Invasive Breast Cancer
Helen Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
